Drug-tolerant persister cells in cancer therapy resistance

PK Dhanyamraju, TD Schell, S Amin, GP Robertson - Cancer research, 2022 - AACR
One of the current stumbling blocks in our fight against cancer is the development of
acquired resistance to therapy, which is attributable to approximately 90% of cancer-related …

Myeloid-derived suppressor cells and radiotherapy

C Jiménez-Cortegana, C Galassi, V Klapp… - Cancer Immunology …, 2022 - AACR
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of pathologically
activated, mostly immature, myeloid cells that exert robust immunosuppressive functions …

PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway

R Zhang, M Dong, J Tu, F Li, Q Deng, J Xu… - Signal transduction and …, 2023 - nature.com
Our previous studies have showed that CC motif chemokine ligand 20 (CCL20) advanced
tumor progression and enhanced the chemoresistance of cancer cells by positively …

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors

Y Wei, Y Li, Y Chen, P Liu, S Huang, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Solid tumors can be divided into benign solid tumors and solid malignant tumors in the
academic community, among which malignant solid tumors are called cancers. Cancer is …

In situ generation of copper (Ⅱ)/diethyldithiocarbamate complex through tannic acid/copper (Ⅱ) network coated hollow mesoporous silica for enhanced cancer …

Y Zhu, N Wang, J Ling, L Yang, AM Omer… - Journal of Colloid and …, 2024 - Elsevier
The Cu 2+ complex formed by the coordination of disulfiram (DSF) metabolite
diethyldithiocarbamate (DTC), Cu (DTC) 2, can effectively inhibit tumor growth. However …

Understanding and overcoming immunosuppression shaped by cancer stem cells

L Li, RA Jensen - Cancer Research, 2023 - AACR
Use of immunotherapy in recent years has revolutionized cancer treatment for certain types
of cancers. However, the broad utility of immunotherapy is limited because there are still …

Cancer stem cells: Recent insights and therapies

H Zhou, L Tan, B Liu, XY Guan - Biochemical Pharmacology, 2023 - Elsevier
Tumors are intricate ecosystems containing malignant components that generate adaptive
and evolutionarily driven abnormal tissues. Through self-renewal and differentiation …

DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma

Z Wang, S Tang, L Cai, Q Wang, D Pan, Y Dong… - British Journal of …, 2024 - nature.com
Background Mitochondrial dynamics play a fundamental role in determining stem cell fate.
However, the underlying mechanisms of mitochondrial dynamics in the stemness acquisition …

ALDH1A1 in cancers: bidirectional function, drug resistance, and regulatory mechanism

H Yue, Z Hu, R Hu, Z Guo, Y Zheng, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Aldehyde dehydrogenases 1 family member A1 (ALDH1A1) gene codes a cytoplasmic
enzyme and shows vital physiological and pathophysiological functions in many areas …

PVT1 inhibition stimulates anti-tumor immunity, prevents metastasis, and depletes cancer stem cells in squamous cell carcinoma

Z Qin, W Zhang, S Liu, Y Wang, X Peng, L Jia - Cell Death & Disease, 2023 - nature.com
Cancer stem cells (CSCs) cause tumor metastasis and immune evasion by as-yet-unknown
molecular mechanisms. In the present study, we identify a long noncoding RNA (lncRNA) …